Replies to post #386634 on Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

"Wouldn’t be surprised if they ditch the partnership after the CV19 blunder."

I see no reason for them not to give this a whirl. It's a huge market, slowly filling up with effective, but relatively dangerous and often expensive immunologics. And Alfasigma is heavily involved with IBD.